CompletedPhase 3

Clinical Study to Assess the Efficacy and Safety of G238 Compared to Clotrimazole Otic Solution in the Treatment of Otomycosis

Spain190 participantsStarted 2013-05

Plain-language summary

The purpose of this study is to evaluate the safety and efficacy of G238 for the treatment of otomycosis

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * 18 years or older. * Clinical diagnosis of otomycosis where topical treatment is indicated. Exclusion Criteria: * Other ear diseases.

What they're measuring

Proportion of Subjects With a Complete Response to Treatment

Timeframe: Day 24

Trial details

NCT IDNCT01993823

SponsorSalvat

Sponsor typeINDUSTRY

Study typeINTERVENTIONAL

Primary completion2014-11

Results submitted2016-12-21

View on ClinicalTrials.gov More Otomycosis trials